Vincerx Pharma (VINC) Financials

$0.02

$0.00 (0.00%)

As on 15-Sep-2026 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	1.07	--	--	--	--	--
Cost of Revenue	0.83	1.09	0.92	0.94	0.34	0.17
Gross Profit	-0.01	-1.09	-0.92	-0.94	-0.34	-0.17
Operating Expenses	27.32	31.46	41.69	71.11	62.66	10.71
Operating Profit (EBIT)	-27.32	-31.46	-42.61	-68.72	-62.66	-10.71
Other Income	--	--	--	--	--	-5.90
Profit before Tax	-22.65	-30.07	-40.16	-62.98	-39.31	-10.72
Provision for Tax	-0.22	--	--	-8.21	-23.70	0.01
Profit after Tax (Net Income)	-22.65	-30.07	-40.16	-65.37	-39.31	-10.73
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-65.37	-39.31	-10.72

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	2.07	2.72	11.22	47.67	100.32	25.38
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	1.39	2.46	3.44	0.49
Current Liabilities	2.62	5.28	5.61	9.16	13.92	37.81
Total Liabilities	7.31	8.01	18.22	59.29	117.68	63.19

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	--	1.60	3.48	3.32	5.84	0.08
Current Assets	4.69	6.41	14.73	55.96	111.84	63.11
Total Assets	7.31	8.01	18.22	59.29	117.68	63.19
Total Debt*	--	--	2.50	3.44	4.17	--
Net Current Assets	2.07	1.13	9.13	46.81	97.92	57.61

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-26.13	-40.45	-59.60	-33.40	-2.28
Cash Flow from Investing Activities	--	0.21	41.50	-40.58	-5.26	-65.64
Cash from Financing Activities	--	17.99	0.11	0.28	88.45	64.07
Net Cash Inflow / Outflow	--	--	--	--	--	61.79

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-4.22	-5.75	-6.80	-11.21	-6.84	-7.41
Cash EPS ($)	--	-5.54	-6.65	-11.05	-6.78	-7.41
Adjusted Book Value ($)	--	0.52	1.90	8.18	17.45	17.52
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.99	-6.85	-10.22	-5.81	-1.57
Free Cash Flow per Share ($)	--	-4.99	-6.85	-10.22	-6.73	-1.57

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-365.69	-123.89	-84.02	-60.53	-84.70
ROE (%)	-405.32	-431.29	-136.38	-88.34	-62.54	-84.70
ROA (%)	-156.05	-229.38	-103.63	-73.88	-43.46	-33.96
EBIT Margin (%)	-2,557.96	--	--	--	--	--
Net Margin (%)	-2,120.32	--	--	--	--	181.93
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-18.72	--	--	--	--	--
EBIT Growth (%)	22.80	18.94	36.24	-60.24	-266.87	-23,708.89
Net Profit Growth (%)	40.79	25.11	38.57	-66.30	-266.32	-19,770.37
EPS Growth (%)	35.10	0.16	0.39	-0.64	0.08	-195.58
Book Value Growth (%)	474.51	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.05	-0.17	-0.09	-1.49	-2.82
Price / Book Value	0.04	0.50	0.62	0.12	0.58	1.19
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.13	0.11	0.08	0.69	1.25	2.94
Close Price ($)	0.53	5.26	23.60	20.40	203.80	418.20
High Price ($)	136.80	187.44	39.00	211.20	535.00	445.60
Low Price ($)	0.48	3.51	12.20	12.62	176.40	187.00
Market Cap ($ Cr)	0.07	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	--	0.22	0.07	0.04	--
Short term debt to equity ratio	--	--	0.10	0.02	0.01	--
Current Ratio	1.79	1.21	2.63	6.11	8.04	1.67
Quick Ratio	1.79	--	--	6.25	--	--
Interest Coverage	--	--	--	-7.67	-1.68	-1,339.25

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.07	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-494.19	-481.55	--	--
Payable days	--	758.31	1,309.71	1,183.27	1,348.20	555.28
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.